Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: Reversal effect of fluvastatin therapy

Journal of Pharmacology and Experimental Therapeutics

Volumn 319, Issue 3, 2006, Pages 1348-1354

  Matsuda, Naoyuki ^a   Hayashi, Yukio ^b   Takahashi, Yoshika ^a   Hattori, Yuichi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLUINDOSTATIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME PHOSPHORYLATION; ENZYME SUBUNIT; GENE TRANSLOCATION; IMMUNOBLOTTING; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SEPSIS; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; BLOTTING, WESTERN; ENZYME INHIBITORS; FATTY ACIDS, MONOUNSATURATED; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; MALE; MESENTERIC ARTERIES; NITRIC OXIDE SYNTHASE TYPE III; ONCOGENE PROTEIN V-AKT; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; RABBITS; SEPSIS; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TISSUE EXTRACTS;

EID: 33751166411     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.109785     Document Type: Article

References (40)

1. Bi L, Okabe I, Bernard DJ, Wynshaw-Boris A, and Nussbaum RL (1999) Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110α subunit of phosphoinositide 3-kinase. J Biol Chem 274:10963-10968.
2. Bommhardt U, Chang KC, Swanson PE, Wagner TH, Tinsley KW, Karl IE, and Hotchkiss RS (2004) Akt decreases lymphocyte apoptosis and improves survival in sepsis. J Immunol 172:7583-7591.
3. Carpenter CL, Duckworth BC, Auger KR, Cohen B, Schaffhausen BS, and Cantley LC (1990) Purification and characterization of phosphoinositide 3-kinase from rat liver. J Biol Chem 265:19704-19711.
4. Connelly L, Madhani M, and Hobbs AJ (2005) Resistance to endotoxic shock in endothelial nitric-oxide synthase (eNOS) knock-out mice. A pro-inflammatory role for eNOS-derived NO in vivo. J Biol Chem 280:10040-10046.
5. Datta K, Bellacosa A, Chan TO, and Tsichlis PN (1996) Akt is a direct target of the phosphatidylinositol 3-kinase: activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells. J Biol Chem 271:30835-30839.
6. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rütten H, Fichtlscherer S, Martin H, and Zeiher AM (2001) HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI3-kinase/Akt pathway. J Clin Investig 108:391-397.
7. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, and Zeiher AM (1999) Activation of nitric oxide synthase in endothelial cells via Akt-dependent phosphorylation. Nature (Lond) 399:601-605.
8. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, and Sessa WC (1999) Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature (Lond) 399:597-601.
9. Gaston B, Drazen JM, Loscalzo J, and Stamler JS (1994) The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 149:538-551.
10. Goldstein JL and Brown MS (1990) Regulation of the mevalonate pathway. Nature (Lond) 343:425-430.
11. Guha M and Mackman N (2002) The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 277:32124-32132.
12. Klippel A, Kavanaugh WM, Pot D, and Williams LT (1997) A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin domain. Mol Cell Biol 17:338-344.
13. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, Sessa WC, and Walsh K (2000) The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6:1004-1010.
14. Kwak B, Mulhaupt F, Myit S, and Mach F (2000) Statins as a newly recognized type of immunomodulator. Nat Med 6:1399-1402.
15. Laufs U, Gertz K, Huang P, Nickenig G, Böhm M, Dirnagl U, and Endres M (2000) Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31:2437-2449.
16. Laufs U, La Fata V, and Liao JK (1997) Inhibition of 3-hydroxy-3- methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J Biol Chem 272:31725-31729.
17. Laufs U, La Fata V, Plutzky J, and Liao JK (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97:1129-1135.
18. Lee T-S, Chang C-C, Zhu Y, and Shyy Y-J (2004) Simvastatin induced heme oxygenase-1. A novel mechanism of vessel protection. Circulation 110:1296-1302.
19. Lefer DJ (2002) Statins as potent antiinflammatory drugs. Circulation 106:2041-2042.
20. sα in septic rabbits. Anesthesiology 93:1465-1473.
21. Matsuda N, Hattori Y, Gando S, Akaishi Y, Kemmotsu O, and Kanno M (1999) Diabetes-induced down-regulation of β1-adrenoceptor mRNA expression in rat heart. Biochem Pharmacol 58:881-885.
22. 2-receptor gene expression during endotoxemia. Naunyn-Schmiedeberg's Arch Pharmacol 366:513-521.
23. Matsuda N, Hattori Y, Takahashi Y, Nishihira J, Jesmin S, Kobayashi M, and Gando S (2004) Therapeutic effect of in vivo transfection of transcription factor decoy to NF-κB on septic lung in mice. Am J Physiol 287:L1248-L1255.
24. 1-receptors. J Pharmacol Exp Ther 307:175-181.
25. Merx MW, Liehn EA, Janssens U, Lütticken R, Schrader J, Hanrath P, and Weber C (2004) HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation 109:2560-2565.
26. Moncada S, Palmer PMJ, and Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142.
27. Monick MM, Carter AB, Robeff PK, Flaherty DM, Peterson MW, and Hunninghake GW (2001) Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of β-catenin. J Immunol 166:4713-4720.
28. Nishimatsu H, Suzuki E, Satonaka H, Takeda R, Omata M, Fujita T, Nagai R, Kitamura T, and Hirata Y (2005) Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats. Am J Physiol 288:1770-1776.
29. Pahan K, Raymond JR, and Singh I (1999) Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells. J Biol Chem 274:7528-7536.
30. Park YC, Lee CH, Kang HS, Chung HT, and Kim HD (1997) Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, enhances LPS-induced NO production from murine peritoneal macrophages. Biochem Biophys Res Commun 240:692-696.
31. Peters K, Unger RE, Brunner J, and Kirkpatrick CJ (2003) Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res 60:49-57.
32. Romashkova JA and Makarov SS (1999) NF-kB is a target of AKT in anti-apoptotic PDGF signaling. Nature (Lond) 401:86-90.
33. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, and Smithies O (1996) Elevated blood pressure in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 93:13176-13181.
34. Skaletz-Rorowski A, Lutchman M, Kureishi Y, Lefer DJ, Faust JR, and Walsh K (2003) HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells. Cardiovasc Res 57:253-264.
35. Tengku-Muhammad TS, Hughes TR, Cryer A, and Ramji DP (1999) Involvement of both the tyrosine kinase and the phosphatidylinositol-3′ kinase signal transduction pathways in the regulation of lipoprotein lipase expression in J774.2 macrophages by cytokines and lipopolysaccharide. Cytokine 11:463-468.
36. Titheradge MA (1999) Nitric oxide in septic shock. Biochim Biophys Acta 1411:437-455.
37. Vanhaesebroeck B and Waterfield MD (1999) Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253:239-254.
38. Walter DH, Dimmeler S, and Zeiher AM (2004) Effects of statins on endothelium and endothelial progenitor cell recruitment. Semin Vasc Med 4:385-393.
39. Yamashita T, Kawashima S, Ohashi Y, Ozaki M, Ueyama T, Ishida T, Inoue N, Hirata K, Akita H, and Yokoyama M (2000) Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase. Circulation 101:931-937.
40. Yellaturu CR, Bhanoori M, Neeli I, and Rao GN (2002) N-Ethylmaleimide inhibits platelet-derived growth factor BB-stimulated Akt phosphorylation via activation of protein phosphatase 2A. J Biol Chem 277:40148-40155.